Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Rauh

Showing results (111-120 of 159) with videos related to

Pageof 16
Sort By:
ACS Chemical Biology|May 2, 2012
Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungalsChristian Grütter, Jeffrey R Simard, Svenja C Mayer-Wrangowski, et al.
Journal of Medicinal Chemistry|May 2, 2023
Fragtory: Pharmacophore-Focused Design, Synthesis, and Evaluation of an sp<sup>3</sup>-Enriched Fragment LibraryMike Bührmann, Shivakrishna Kallepu, Jonas D Warmuth, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2010
A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyronesStefan Wetzel, Wolfram Wilk, Samy Chammaa, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 30, 2019
2-Azo-, 2-diazocine-thiazols and 2-azo-imidazoles as photoswitchable kinase inhibitors: limitations and pitfalls of the photoswitchable inhibitor approachMiriam Schehr, Chiara Ianes, Jörn Weisner, et al.
Scientific Reports|March 28, 2026
Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma modelsLeonhard Koch, Maximilian Kerkhoff, Maximilian Bretschneider, et al.
Nature Chemical Biology|June 30, 2009
Bioactivity-guided mapping and navigation of chemical spaceSteffen Renner, Willem A L van Otterlo, Marta Dominguez Seoane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
ALK mutations conferring differential resistance to structurally diverse ALK inhibitorsJohannes M Heuckmann, Michael Hölzel, Martin L Sos, et al.
Journal of Medicinal Chemistry|December 29, 2012
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activityStefan Fischer, Heike K Wentsch, Svenja C Mayer-Wrangowski, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2017
Optimized Target Residence Time: Type I1/2 Inhibitors for p38α MAP Kinase with Improved Binding Kinetics through Direct Interaction with the R-SpineHeike K Wentsch, Niklas M Walter, Mike Bührmann, et al.
Pageof 16

Showing results (111-120 of 159) with videos related to

Sort By:
Pageof 16
ACS Chemical Biology|May 2, 2012
Targeting GSK3 from Ustilago maydis: type-II kinase inhibitors as potential antifungalsChristian Grütter, Jeffrey R Simard, Svenja C Mayer-Wrangowski, et al.
Journal of Medicinal Chemistry|May 2, 2023
Fragtory: Pharmacophore-Focused Design, Synthesis, and Evaluation of an sp<sup>3</sup>-Enriched Fragment LibraryMike Bührmann, Shivakrishna Kallepu, Jonas D Warmuth, et al.
Journal of Medicinal Chemistry|January 22, 2025
Design, Synthesis, and SAR of Covalent KIT and PDGFRA Inhibitors─Exploring Their Potential in Targeting GISTTom Schulz, Rajesh Gontla, Alina Teuber, et al.
Angewandte Chemie (International Ed. in English)|April 16, 2010
A scaffold-tree-merging strategy for prospective bioactivity annotation of gamma-pyronesStefan Wetzel, Wolfram Wilk, Samy Chammaa, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|March 30, 2019
2-Azo-, 2-diazocine-thiazols and 2-azo-imidazoles as photoswitchable kinase inhibitors: limitations and pitfalls of the photoswitchable inhibitor approachMiriam Schehr, Chiara Ianes, Jörn Weisner, et al.
Scientific Reports|March 28, 2026
Elimusertib enhances cytotoxic effects of conventional chemotherapy and sensitizes to radiation in preclinical Ewing sarcoma modelsLeonhard Koch, Maximilian Kerkhoff, Maximilian Bretschneider, et al.
Nature Chemical Biology|June 30, 2009
Bioactivity-guided mapping and navigation of chemical spaceSteffen Renner, Willem A L van Otterlo, Marta Dominguez Seoane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 28, 2011
ALK mutations conferring differential resistance to structurally diverse ALK inhibitorsJohannes M Heuckmann, Michael Hölzel, Martin L Sos, et al.
Journal of Medicinal Chemistry|December 29, 2012
Dibenzosuberones as p38 mitogen-activated protein kinase inhibitors with low ATP competitiveness and outstanding whole blood activityStefan Fischer, Heike K Wentsch, Svenja C Mayer-Wrangowski, et al.
Angewandte Chemie (International Ed. in English)|April 12, 2017
Optimized Target Residence Time: Type I1/2 Inhibitors for p38α MAP Kinase with Improved Binding Kinetics through Direct Interaction with the R-SpineHeike K Wentsch, Niklas M Walter, Mike Bührmann, et al.
Pageof 16